Skip to content

Tenoxicam for Intrapartum Analgesia

Efficacy of Intravenous Tenoxicam as an Analgesic During the First Stage of Labor: A Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02549118
Enrollment
100
Registered
2015-09-15
Start date
2015-09-30
Completion date
2016-03-31
Last updated
2015-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Obstetrical

Brief summary

The aim of this study is to assess whether tenoxicam is as effective as pethidine for analgesia during the first stage of labor.

Interventions

DRUGPethidine

Sponsors

Ain Shams Maternity Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Primiparity * Active phase of labor (cervical dilatation of 3-5 cm, in the presence of adequate uterine contractions; lasting at least 40 seconds at intervals of 3-4 minutes) * Maternal age between 20-30 years * Singleton term pregnancy (37-42 weeks of gestation) * Vertex-presenting fetus

Exclusion criteria

* Clinical evidence of cephalopelvic disproportion * Scarred uterus; previous cesarean section, hysterotomy or myomectomy * Medical disorders associated with pregnancy, especially gastritis, peptic ulcer, bronchial asthma or renal impairment * Fetal distress * Receiving any regional or parenteral analgesia before recruitment in the study * Known hypersensitivity to the drug family

Design outcomes

Primary

MeasureTime frameDescription
The efficacy of intravenous tenoxicam to supply adequate analgesia as indicated by changes in the pain intensity score using the visual analog scale4 hoursAssessment is to be done and followed up by the investigator at ½, 1, 2, 3 and 4 hours from drug administration. Scores range from 0 \[no pain\] to 10 \[worst possible pain\].

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026